XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses    
Research and development $ 8,113 $ 6,635
General and administrative 2,997 3,224
Total operating expenses 11,110 9,859
Loss from operations (11,110) (9,859)
Other income (expense), net 338 (5)
Net loss and comprehensive loss $ (10,772) $ (9,864)
Net loss per share, Basic $ (0.75) $ (0.69)
Net loss per share, Diluted $ (0.75) $ (0.69)
Weighted-average common shares outstanding, Basic 14,285,905 14,330,693
Weighted Average Number of Shares Outstanding, Diluted 14,285,905 14,330,693